arginine vasopressin receptor 2
Dernière mise à jour 13 août 2024
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
The AVPR2 gene provides instructions for making a protein known as the vasopressin V2 receptor. This receptor works together with a hormone called arginine vasopressin (AVP), which is sometimes also called antidiuretic hormone (ADH). The vasopressin V2 receptor is found in the kidneys in structures called collecting ducts, which are a series of small tubes that reabsorb water from the kidneys into the bloodstream.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
The AVPR2 gene provides instructions for making a protein known as the vasopressin V2 receptor. This receptor works together with a hormone called arginine vasopressin (AVP), which is sometimes also called antidiuretic hormone (ADH). The vasopressin V2 receptor is found in the kidneys in structures called collecting ducts, which are a series of small tubes that reabsorb water from the kidneys into the bloodstream.
The interaction between AVP and the vasopressin V2 receptor triggers chemical reactions that control the body's water balance. When a person's fluid intake is low or when a lot of fluid is lost (for example, through sweating), AVP is released from the brain, where it is produced and stored. In the kidneys, this hormone attaches (binds) to the vasopressin V2 receptor and directs the kidneys to concentrate urine by reabsorbing some of the water back into the bloodstream. When fluid intake is adequate, the brain releases less AVP. At these times, less water is reabsorbed into the bloodstream and the urine is more dilute.
Conditions referring to this gene or chromosome
Other names
ADHR
antidiuretic hormone receptor
AVPR V2
V2R
V2R_HUMAN
vasopressin V2 receptor
Related patient information and medicines

Patient information leaflet
Osmolalité, osmolarité et homéostasie des fluides
In normal, healthy people the osmolality of the body's fluids is very closely regulated by the body. As the osmolality goes up You get a desire to drink - thirst. The brain releases a hormone called antidiuretic hormone (ADH) (also known as arginine vasopressin (AVP)). ADH changes the way the kidneys react to blood flowing through them. The.

Patient information leaflet
Myasthénie grave
Myasthenia gravis (MG) is a condition where muscles become easily tired and weak. It is due to a problem with how the nerves stimulate the muscles to tighten (contract). The muscles around the eyes are commonly affected first. What causes myasthenia gravis. Myasthénie grave est an autoimmune disease. This means that the immune system The immune.

Patient information leaflet
Maladie rénale diabétique
An angiotensin-II receptor antagonist (AIIRA) There are several types and brands of this type of medication. The ones available in the UK are: azilsartan Azilsartan - an angiotensin receptor blocker , candesartan Candesartan - an angiotensin receptor blocker , eprosartan Eprosartan - an angiotensin receptor blocker , irbesartan Irbesartan - an.

Patient information leaflet
Alpha-bloquants
Alpha-bloquants are medicines that are mainly used to treat high blood pressure (hypertension) and problems with passing urine in men who have enlargement of the prostate gland. Prostate gland enlargement is also called benign prostatic hyperplasia (BPH). What are alpha-blockers used for. In the past, some alpha-blockers were also used to treat.

Patient information leaflet
Puis-je prendre Diazépam et Tirzépatide ensemble ?
Additionally, both medications can cause drowsiness or slowed reactions. Why this happens Tirzepatide est a GLP-1 and GIP receptor agonist cela delays gastric emptying (the rate at which food and pills leave the stomach). This can delay the absorption (Tmax) of oral medications like diazepam. There is also a potential for additive central nervo....

Patient information leaflet
Régime 5:2
La Régime 5:2 is a calorie-restricted diet that involves eating 'normally' for five days out de seven and then 'fasting' on the other two days out of seven. The proposed health effects of the 5:2 diet include weight loss, improvement in life expectancy, protection against certain cancers and protection against dementia. However, the evidence.
Lectures complémentaires et références
- arginine vasopressin receptor 2; MedlinePlus, National Library of Medicine.
- Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, DE Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bichet DG, Fujiwara TM. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol. 2000 Jun;11(6):1044-1054. doi: 10.1681/ASN.V1161044.
- Bichet DG. Vasopressin receptor mutations in nephrogenic diabetes insipidus. Semin Nephrol. 2008 May;28(3):245-51. doi: 10.1016/j.semnephrol.2008.03.005.
- Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005 May 5;352(18):1884-90. doi: 10.1056/NEJMoa042743.
- Hureaux M, Vargas-Poussou R. Genetic basis of nephrogenic diabetes insipidus. Mol Cell Endocrinol. 2023 Jan 15;560:111825. doi: 10.1016/j.mce.2022.111825. Epub 2022 Nov 30.
- Knoers NV. Hyperactive vasopressin receptors and disturbed water homeostasis. N Engl J Med. 2005 May 5;352(18):1847-50. doi: 10.1056/NEJMp058006. No abstract available.
- Robben JH, Knoers NV, Deen PM. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2006 Aug;291(2):F257-70. doi: 10.1152/ajprenal.00491.2005.
- Rosenthal SM, Feldman BJ, Vargas GA, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction. Pediatr Endocrinol Rev. 2006 Dec;4 Suppl 1:66-70.
- Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. 2008 Dec;217(3):605-17. doi: 10.1002/jcp.21552.
- Valenti G, Tamma G. The vasopressin-aquaporin-2 pathway syndromes. Handb Clin Neurol. 2021;181:249-259. doi: 10.1016/B978-0-12-820683-6.00018-X.
Historique de l'article
Article également disponible en Anglais, Allemand, Espagnol, Français, Italien, Portugais, Hindi, Hébreu, Arabe, and Suédois.
13 août 2024 | Dernière version
1 août 2024 | Publié à l'origine
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

